Compare Elder Pharma with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA PIRAMAL ENTERPRISES ELDER PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x -0.2 15.5 - View Chart
P/BV x 0.1 1.0 10.2% View Chart
Dividend Yield % 0.0 1.8 -  

Financials

 ELDER PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
PIRAMAL ENTERPRISES
Mar-19
ELDER PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3803,303 11.5%   
Low Rs1881,797 10.5%   
Sales per share (Unadj.) Rs491.2716.5 68.6%  
Earnings per share (Unadj.) Rs-3.279.7 -4.0%  
Cash flow per share (Unadj.) Rs14.4107.9 13.4%  
Dividends per share (Unadj.) Rs028.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs376.51,477.5 25.5%  
Shares outstanding (eoy) m20.54184.45 11.1%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x0.63.6 16.2%   
Avg P/E ratio x-89.332.0 -279.0%  
P/CF ratio (eoy) x19.723.6 83.4%  
Price / Book Value ratio x0.81.7 43.7%  
Dividend payout %035.1 0.0%   
Avg Mkt Cap Rs m5,833470,292 1.2%   
No. of employees `000NA7.8 0.0%   
Total wages/salary Rs m2,17922,504 9.7%   
Avg. sales/employee Rs ThNM16,899.4-  
Avg. wages/employee Rs ThNM2,877.7-  
Avg. net profit/employee Rs ThNM1,879.9-  
INCOME DATA
Net Sales Rs m10,089132,153 7.6%  
Other income Rs m2573,128 8.2%   
Total revenues Rs m10,346135,281 7.6%   
Gross profit Rs m-79266,290 -1.2%  
Depreciation Rs m3615,202 6.9%   
Interest Rs m2,75644,097 6.3%   
Profit before tax Rs m-3,65320,119 -18.2%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1258,611 1.5%   
Profit after tax Rs m-6514,701 -0.4%  
Gross profit margin %-7.850.2 -15.6%  
Effective tax rate %-3.442.8 -8.0%   
Net profit margin %-0.611.1 -5.8%  
BALANCE SHEET DATA
Current assets Rs m9,240122,742 7.5%   
Current liabilities Rs m9,998310,810 3.2%   
Net working cap to sales %-7.5-142.3 5.3%  
Current ratio x0.90.4 234.0%  
Inventory Days Days4623 200.8%  
Debtors Days Days6039 154.3%  
Net fixed assets Rs m10,124116,904 8.7%   
Share capital Rs m206369 55.8%   
"Free" reserves Rs m5,582272,161 2.1%   
Net worth Rs m7,734272,530 2.8%   
Long term debt Rs m4,889270,196 1.8%   
Total assets Rs m22,882856,261 2.7%  
Interest coverage x-0.31.5 -22.3%   
Debt to equity ratio x0.61.0 63.8%  
Sales to assets ratio x0.40.2 285.7%   
Return on assets %11.86.9 171.3%  
Return on equity %-0.85.4 -15.7%  
Return on capital %22.312.4 179.6%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30715,200 2.0%   
Fx outflow Rs m1254,889 2.6%   
Net fx Rs m18110,312 1.8%   
CASH FLOW
From Operations Rs m11,754-115,975 -10.1%  
From Investments Rs m-561-8,265 6.8%  
From Financial Activity Rs m-6,762107,525 -6.3%  
Net Cashflow Rs m4,432-16,650 -26.6%  

Share Holding

Indian Promoters % 39.6 52.9 74.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 4.0 187.5%  
FIIs % 16.8 26.6 63.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 16.5 218.8%  
Shareholders   16,479 93,274 17.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   ORCHID PHARMA LTD  WYETH LTD  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare ELDER PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS